DK484785D0 - Bromcryptinholdige oejendraaber - Google Patents

Bromcryptinholdige oejendraaber

Info

Publication number
DK484785D0
DK484785D0 DK484785A DK484785A DK484785D0 DK 484785 D0 DK484785 D0 DK 484785D0 DK 484785 A DK484785 A DK 484785A DK 484785 A DK484785 A DK 484785A DK 484785 D0 DK484785 D0 DK 484785D0
Authority
DK
Denmark
Prior art keywords
bromcrypt
contents
bromcrypt contents
Prior art date
Application number
DK484785A
Other languages
English (en)
Other versions
DK484785A (da
Inventor
Thomas Cavanak
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK484785D0 publication Critical patent/DK484785D0/da
Publication of DK484785A publication Critical patent/DK484785A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK484785A 1984-10-24 1985-10-22 Bromcryptinholdige oejendraaber DK484785A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848426922A GB8426922D0 (en) 1984-10-24 1984-10-24 Galenic formulation

Publications (2)

Publication Number Publication Date
DK484785D0 true DK484785D0 (da) 1985-10-22
DK484785A DK484785A (da) 1986-04-25

Family

ID=10568697

Family Applications (1)

Application Number Title Priority Date Filing Date
DK484785A DK484785A (da) 1984-10-24 1985-10-22 Bromcryptinholdige oejendraaber

Country Status (15)

Country Link
US (1) US4654345A (da)
JP (1) JPS61103825A (da)
AU (1) AU4892885A (da)
BE (1) BE903483A (da)
DE (1) DE3536560A1 (da)
DK (1) DK484785A (da)
FR (1) FR2571962A1 (da)
GB (2) GB8426922D0 (da)
GR (1) GR852545B (da)
IL (1) IL76781A0 (da)
IT (1) IT1237360B (da)
NL (1) NL8502805A (da)
PT (1) PT81352B (da)
SE (1) SE8504976L (da)
ZA (1) ZA858184B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2012532A6 (es) * 1988-07-15 1990-04-01 Cusi Lab Un procedimiento para la preparacion de una solucion acuosa de b-metil-4-(2' -tienilcarbonil)fenilacetato de lisina para aplicacion topica oftalmica.
CA2030174C (en) * 1990-01-10 1996-12-24 Anthony H. Cincotta Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
FR2661832A1 (fr) * 1990-05-11 1991-11-15 Corbiere Jerome Procede de stabilisation d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.
US5262422A (en) * 1991-05-02 1993-11-16 Sandoz Ltd. Octahydrobenzo[g]quinoline
FR2680106B1 (fr) * 1991-08-09 1994-03-11 Corbiere Gerome Procede de realisation de formes pharmaceutiques stables d'un derive d'ergoline et les compositions pharmaceutiques ainsi obtenues.
EP0782850A4 (en) * 1994-10-13 1998-03-04 Wakamoto Pharma Co Ltd LYOPHILIZED PREPARATION FOR PRODUCING A REVERSIBLE THERMOGELING MEDICINAL WATER-BASED
GB9600426D0 (en) * 1996-01-10 1996-03-13 Ed Geistlich Sohne A G Compositions
US20070275955A1 (en) * 1997-07-31 2007-11-29 Ed. Geistlich Soehne Ag Method of treating tumors
US20050124608A1 (en) * 2001-04-03 2005-06-09 Redmond H. P. Treatment of cancers
US8304390B2 (en) 1997-07-31 2012-11-06 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Method of treatment for preventing or reducing tumor growth in the liver of patient
US7892530B2 (en) 1999-06-04 2011-02-22 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of tumor metastases and cancer
US6821968B2 (en) 2001-09-26 2004-11-23 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Stable taurolidine electrolyte solutions
US8030301B2 (en) 1999-06-04 2011-10-04 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of cancers with methylol-containing compounds and at least one electrolyte
US7345039B2 (en) 1999-06-04 2008-03-18 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
CN109689057A (zh) 2016-04-20 2019-04-26 维罗技术有限责任公司 用于治疗代谢失调的组合物和方法
EP3697418B1 (en) 2017-10-18 2024-07-24 VeroScience LLC Improved bromocriptine formulations
PL430675A1 (pl) * 2019-07-23 2021-01-25 Osęka Maciej Bromokryptyna do zastosowania w leczeniu chorób oczu związanych z podwyższonym poziomem śródbłonkowego czynnika wzrostu naczyń (VEGF) oraz kompozycja farmaceutyczna zawierająca bromokryptynę

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5637967B2 (da) * 1973-05-17 1981-09-03
CH601321A5 (da) * 1975-01-06 1978-07-14 Sandoz Ag
US4039662A (en) * 1975-12-04 1977-08-02 Alcon Laboratories, Inc. Ophthalmic solution
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
YU216177A (en) * 1977-09-09 1984-02-29 Rudolf Rucman Process for preparing 2-bromo ergosine
YU40533B (en) * 1978-09-04 1986-02-28 Lek Tovarna Farmacevtskih Process for preparing 2-bromoergosinine
CH642259A5 (de) * 1978-12-21 1984-04-13 Sandoz Ag Galenische zubereitungen fuer orale applikation von ergotalkaloiden.
US4283393A (en) * 1979-03-13 1981-08-11 Merck & Co., Inc. Topical application of interferon inducers
DE3020895A1 (de) * 1979-06-12 1980-12-18 Sandoz Ag Ergopeptinderivate, verfahren zu deren herstellung sowie diese ergopeptinderivate enthaltende pharmazeutischen zusammensetzungen
CA1141663A (en) * 1979-09-06 1983-02-22 Yukihisa Ishii Ophthalmic solution for intraocular pressure adjustment
GB2058746A (en) * 1979-09-20 1981-04-15 Erba Farmitalia 6,7-Secoergolines
DE3033898A1 (de) * 1980-09-09 1982-04-22 Dr. Thilo & Co GmbH, 8021 Sauerlach Arzneimittel zur lokalen behandlung des glaukoms
BE890369A (fr) * 1980-09-18 1982-03-16 Sandoz Sa Nouveaux medicaments a base d'inhibiteurs de la secretion de la prolactine pour le traitement de l'arteriosclerose
US4486416A (en) * 1981-03-02 1984-12-04 Soll David B Protection of human and animal cells subject to exposure to trauma

Also Published As

Publication number Publication date
PT81352B (en) 1987-08-05
IT1237360B (it) 1993-05-31
SE8504976L (sv) 1986-04-25
AU4892885A (en) 1986-07-17
SE8504976D0 (sv) 1985-10-22
JPS61103825A (ja) 1986-05-22
DE3536560A1 (de) 1986-04-24
GB8525947D0 (en) 1985-11-27
GR852545B (da) 1986-02-18
BE903483A (fr) 1986-04-21
FR2571962A1 (fr) 1986-04-25
IL76781A0 (en) 1986-02-28
NL8502805A (nl) 1986-05-16
GB8426922D0 (en) 1984-11-28
GB2165752A (en) 1986-04-23
DK484785A (da) 1986-04-25
PT81352A (en) 1985-11-01
ZA858184B (en) 1987-06-24
US4654345A (en) 1987-03-31
IT8548703A0 (it) 1985-10-23

Similar Documents

Publication Publication Date Title
DE3568434D1 (de) Organocyclosiloxane
DK484785D0 (da) Bromcryptinholdige oejendraaber
FI840995A0 (fi) Fartygsskrov
DK117985D0 (da) Glyceroletherphosphatider
DK446085D0 (da) Triazol- eller imidazolfungicidholdige materialer
PT79789A (de) Winkelschraubvorrichtung
DK78385D0 (da) Diazepinoindoler
KR860004473U (ko) 차 제조용 용기
SE8405679L (sv) Vetskenivagivare
FR2574373B1 (fr) Conteneur
ES276911Y (es) Envase
ES283212Y (es) Envase
ES277724Y (es) Envase
ES277521Y (es) Envase
DK257284D0 (da) Container
SE8402901D0 (sv) Container
BR8406170A (pt) Container
PT7617U (pt) Recipiente
BR8401923A (pt) Aperfeicoamento em container
ES277275Y (es) Envase simplificado
ES278837Y (es) Envase multiple
ES281497Y (es) Envase multiple
PT7578U (pt) Garrafa
ES283358Y (es) Embalaje mejorado
RO89191A2 (ro) Container rigid cu siber

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment